Fatores de risco

BMJ - Risk of hospital admission with coronavirus disease 2019 in healthcare workers and their households: nationwide linkage cohort study

British Medical Journal
To assess the risk of hospital admission for coronavirus disease 2019 (covid-19) among patient facing and non-patient facing healthcare workers and their household members.

BMJ - In-hospital cardiac arrest in critically ill patients with covid-19: multicenter cohort study

British Medical Journal

To estimate the incidence, risk factors, and outcomes associated with in-hospital cardiac arrest and cardiopulmonary resuscitation in critically ill adults with coronavirus disease 2019 (covid-19).

JAMA - Risk of COVID-19 During Air Travel

JAMA NETWORKThe risk of contracting coronavirus disease 2019 (COVID-19) during air travel is lower than from an office building, classroom, supermarket, or commuter train.he risk of contracting coronavirus disease 2019 (COVID-19) during air...

The Lancet - Clinical features of COVID-19 mortality: development and validation of a clinical prediction model

The LancetPredicting mortality among patients with COVID-19 who present with a spectrum of complications is very difficult, hindering the prognostication and management of the disease. We aimed to develop an accurate prediction model of COVID-19...

JAMA - Risk Factors for Hospitalization, Mechanical Ventilation, or Death Among 10 131 US Veterans With SARS-CoV-2 Infection

JAMA NETWORKWhat are the risk factors associated with hospitalization, mechanical ventilation, and death among patients with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection?

BMJ - Risk stratification of patients admitted to hospital with covid-19 using the ISARIC WHO Clinical Characterisation Protocol: development and validation of the 4C Mortality Score

British Medical JournalInternational Severe Acute Respiratory and emerging Infections Consortium (ISARIC) World Health Organization (WHO) Clinical Characterisation Protocol UK (CCP-UK) study (performed by the ISARIC Coronavirus Clinical...

MDPI - The Role of Health Preconditions on COVID-19 Deaths in Portugal: Evidence from Surveillance Data of the First 20293 Infection Cases

Journal of Clinical MedicineIt is essential to study the effect of potential co-factors on the risk of death in patients infected by COVID-19. The identification of risk factors is important to allow more efficient public health and health...

AMP - Population-based Estimates for High Risk of Severe COVID-19 Disease due to Age and Underlying Health Conditions

Acta Médica PortuguesaCOVID-19 is a viral respiratory disease, which became a global threat to public health. Specific subsets of the population are more vulnerable, namely those with chronic diseases. We aimed to estimate the share of the...

NATURE - OpenSAFELY: factors associated with COVID-19 death in 17 million patients

COVID-19 has rapidly affected mortality worldwide. There is unprecedented urgency to understand who is most at risk of severe outcomes, requiring new approaches for timely analysis of large datasets.

CDC updates, expands list of people at risk of severe COVID-19 illness

Centers for Disease Control and PreventionBased on a detailed review of available evidence to date, CDC has updated and expanded the list of who is at increased risk for getting severely ill from COVID-19.

BMJ - Factors associated with hospital admission and critical illness among 5279 people with coronavirus disease 2019 in New York City: prospective cohort study

The British Medical JournalObjective - To describe outcomes of people admitted to hospital with coronavirus disease 2019 (covid-19) in the United States, and the clinical and laboratory characteristics associated with severity of illness.

WHO - Smoking and COVID-19

World Health OrganizationThe harms of tobacco use are well-established. Tobacco causes 8 million deaths every year from cardiovascular diseases, lung disorders, cancers, diabetes, and hypertension.1 Smoking tobacco is also a known risk factor for...

JAMA - Association of Use of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers With Testing Positive for Coronavirus Disease 2019 (COVID-19)

JAMA NETWORKWhat is the association of use of angiotensin-converting enzyme inhibitors (ACEI) and angiotensin II receptor blockers (ARB) with testing positive for coronavirus disease 2019 (COVID-19)?

NEJM - Renin–Angiotensin–Aldosterone System Inhibitors and Risk of Covid-19

The New England Journal of MedicineThere is concern about the potential of an increased risk related to medications that act on the renin–angiotensin–aldosterone system in patients exposed to coronavirus disease 2019 (Covid-19), because the viral...

NEJM - Renin–Angiotensin–Aldosterone System Blockers and the Risk of Covid-19

The New England Journal of MedicineA potential association between the use of angiotensin-receptor blockers (ARBs) and angiotensin-converting–enzyme (ACE) inhibitors and the risk of coronavirus disease 2019 (Covid-19) has not been well studied.